CONTROLLED SUB. PRESCRIPTION; HOSPICE                                         H.B. 4225 (H-2):

                                                                              SUMMARY OF HOUSE-PASSED BILL

                                                                                                         IN COMMITTEE

House Bill 4225 (Substitute H-2 as passed by the House)

Sponsor:  Representative Bronna Kahle

House Committee:  Health Policy

                             Ways and Means

Senate Committee:  Health Policy and Human Services

Date Completed:  5-15-19

CONTENT

The bill would amend Part 73 (Manufacture, Distribution, and Dispensing) of the Public Health Code to exempt a patient who was under the care of a hospice from certain requirements related to the prescription of a controlled substance listed in Schedules 2 to 5.

The bill is tie-barred to House Bill 4224. (House Bill 4224 (H-1) would amend the Public Health Code to define "bona fide prescriber-patient relationship".)

Under Part 73, a prescriber who holds a controlled substances license may administer or dispense a controlled substance listed in Schedules 2 to 5 without a separate controlled substances license. Generally, the Code prohibits a licensed prescriber from prescribing a controlled substance listed in Schedules 2 to 5 unless he or she is in a bona fide prescriber-patient relationship with the patient for whom the controlled substance is being prescribed. Under the bill, this requirement would not apply for a patient who was under the care of a hospice.

Part 73 also requires a licensed prescriber to obtain and review a report concerning a patient from the Michigan Automated Prescription System (MAPS) before prescribing or dispensing to a patient a controlled substance in a quantity that exceeds a three-day supply. This requirement does not apply under certain circumstances, for example, if the controlled substance is prescribed by a veterinarian. Under the bill, the requirement to obtain a MAPS report also would not apply if the patient were under the care of a hospice and the report was obtained and reviewed at the time the patient was admitted to the hospice.

Additionally, the bill would delete the definitions for "bona fide prescriber-patient relationship" and "telehealth".

MCL 333.7303a                                                       Legislative Analyst:  Tyler VanHuyse

FISCAL IMPACT

The bill would have no fiscal impact on State or local government.

                                                                           Fiscal Analyst:  Elizabeth Raczkowski

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.